open access

Vol 11, No 4 (2006)
Published online: 2006-01-01
Submitted: 2005-12-14
Get Citation

Clinical findings and therapeutic options in cardiac tumours

Gorkem Aksu
DOI: 10.1016/S1507-1367(06)71064-1
·
Rep Pract Oncol Radiother 2006;11(4):191-196.

open access

Vol 11, No 4 (2006)
Published online: 2006-01-01
Submitted: 2005-12-14

Abstract

Background

Primary cardiac malignancies are uncommon, with an estimated autopsy incidence of 0.001– 0.05%, and the vast majority of malignancies involving the heart and pericardium are metastatic. Three quarters of these tumours are benign, and approximately half of adult cardiac tumours are myxomas. Rhabdomyomas, papillary fibroelastomas, lipomas, fibromas, and haemangiomas are the other benign tumours. Rhabdomyomas are also the most common paediatric primary cardiac tumours. Primary malignant cardiac malignancies make up one fourth of all cardiac tumours, and angiosarcoma, rhabdomyosarcoma, fibrosarcoma, leiomyosarcoma, malignant fibrous histiocytoma, pericardial mesothelioma and lymphoma are the major neoplasms. The diagnosis is often made by transthoracic echocardiography (TTE) but magnetic resonance imaging (MRI) and computed tomography (CT) are needed to determine the characterization, location and extent of cardiac and paracardiac masses. These imaging modalities are also used for both treatment planning and post-treatment follow-up.

Aim

In this report, we evaluate primary cardiac benign and malignant tumours and metastatic lesions with the treatment strategies by reviewing the recent literature.

Abstract

Background

Primary cardiac malignancies are uncommon, with an estimated autopsy incidence of 0.001– 0.05%, and the vast majority of malignancies involving the heart and pericardium are metastatic. Three quarters of these tumours are benign, and approximately half of adult cardiac tumours are myxomas. Rhabdomyomas, papillary fibroelastomas, lipomas, fibromas, and haemangiomas are the other benign tumours. Rhabdomyomas are also the most common paediatric primary cardiac tumours. Primary malignant cardiac malignancies make up one fourth of all cardiac tumours, and angiosarcoma, rhabdomyosarcoma, fibrosarcoma, leiomyosarcoma, malignant fibrous histiocytoma, pericardial mesothelioma and lymphoma are the major neoplasms. The diagnosis is often made by transthoracic echocardiography (TTE) but magnetic resonance imaging (MRI) and computed tomography (CT) are needed to determine the characterization, location and extent of cardiac and paracardiac masses. These imaging modalities are also used for both treatment planning and post-treatment follow-up.

Aim

In this report, we evaluate primary cardiac benign and malignant tumours and metastatic lesions with the treatment strategies by reviewing the recent literature.

Get Citation

Keywords

cardiac tumours; myxoma; heart; sarcoma

About this article
Title

Clinical findings and therapeutic options in cardiac tumours

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 11, No 4 (2006)

Pages

191-196

Published online

2006-01-01

DOI

10.1016/S1507-1367(06)71064-1

Bibliographic record

Rep Pract Oncol Radiother 2006;11(4):191-196.

Keywords

cardiac tumours
myxoma
heart
sarcoma

Authors

Gorkem Aksu

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl